Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Cedars-Sinai Medical Center |
---|---|
Information provided by: | Cedars-Sinai Medical Center |
ClinicalTrials.gov Identifier: | NCT00576537 |
This research is being determine whether vaccinations with your own immune cells called " dendritic cells " can activate your immune system to fight your brain tumor.
Condition | Intervention | Phase |
---|---|---|
Glioblastoma |
Biological: Dendritic Cell Immunotherapy Biological: Dendritic Cell Vaccine |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Single Group Assignment |
Official Title: | Phase ll Trial of Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Patients With Atypical or Malignant, Primary or Metastatic Brain Tumors of the Central Nervous System |
Estimated Enrollment: | 50 |
Study Start Date: | March 2001 |
Estimated Study Completion Date: | October 2008 |
Arms | Assigned Interventions |
---|---|
1: Experimental |
Biological: Dendritic Cell Immunotherapy
Patients will receive four vaccines.
Biological: Dendritic Cell Vaccine
Four vaccines
Biological: Dendritic Cell Vaccine
Four vaccines will be given to patients
|
To become eligible for therapy the following criteria must be fulfilled:
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Marites O. Francisco, RN | 310 423 0022 | Marites.Francisco@cshs.org |
United States, California | |
Cedars Sinai Medical center | Recruiting |
8700 Beverly Blvd., California, United States, 90048 | |
Contact: Marites O Francisco, RN 310-423-0022 Marites.Francisco@cshs.org | |
Cedars Sinai Medical Center | Recruiting |
8700 Beverly Blvd., California, United States, 90048 | |
Contact: Marites O. Francisco, RN 310-423-0022 Marites.Francisco@cshs.org | |
Principal Investigator: John Yu, M.D. | |
Principal Investigator: John Yu, M.D. |
Principal Investigator: | John Yu, M.D. | Cedars-Sinai Medical Center |
Responsible Party: | Cedars Sinai Medical Center ( John Yu, M.D. ) |
Study ID Numbers: | 3368 |
Study First Received: | December 18, 2007 |
Last Updated: | January 2, 2008 |
ClinicalTrials.gov Identifier: | NCT00576537 |
Health Authority: | United States: Food and Drug Administration |
New/Recurrent Glioblastoma |
Glioblastoma Astrocytoma Central Nervous System Diseases Central Nervous System Neoplasms Brain Diseases Recurrence Brain Neoplasms |
Neuroectodermal Tumors Neoplasms, Germ Cell and Embryonal Neuroepithelioma Glioma Nervous System Neoplasms Neoplasms, Glandular and Epithelial |
Neoplasms Neoplasms by Histologic Type Neoplasms by Site |
Neoplasms, Nerve Tissue Nervous System Diseases Neoplasms, Neuroepithelial |